Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BeyondMD vs GetRelief Rx

BeyondMD
Graded #176

Higher grade

vs+7.899999999999999
GetRelief Rx
Graded #353

Lower grade

The verdict

BeyondMD takes it — 66.8/100 to 58.9/100.

BeyondMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth clinic offering competitively priced compounded semaglutide and tirzepatide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBeyondMD +33
76
43
Dose & formulationGetRelief Rx +14
64
78
Clinical oversightBeyondMD +4
74
70
Labs & monitoringBeyondMD +1
53
52
FulfillmentBeyondMD +7
65
58
Contract termsBeyondMD +8
55
47
BeyondMD · left barGetRelief Rx · right bar

The numbers

MetricBeyondMDGetRelief Rx
WeighScore66.8/10058.9/100
GradeCC
Scorecard rank#176#353
Semaglutide$139/mo (starting dose, compounded)$269/mo (9 mg dose, compounded oral)
Tirzepatide$209/mo (starting dose, compounded)$179/mo (16 mg dose, compounded oral)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
BeyondMD

Graded #176 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
GetRelief Rx

Graded #353 · C

Strengths

  • Compounded semaglutide and tirzepatide priced publicly — no login required to see costs
  • BBB accredited with an A rating (March 2026)
  • Free online assessment with no upfront consultation fee

Where it loses points

  • Sublingual drops only — no injectable; this delivery method wasn't studied in the STEP/SURMOUNT trials
  • Still sells compounded tirzepatide after the FDA ended compounding enforcement discretion in 2025
  • No LegitScript, PCAB, or NABP pharmacy certifications found
  • Prescriber credentials listed only as 'licensed clinicians' with no detail on degree type

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard